Evidence map›Paper›PMID 34390830›Full record

ArticleThe Journal of steroid biochemistry and molecular biology2021

Impact of vitamin D on the course of COVID-19 during pregnancy: A case control study.

Selcan Sinaci, Doga Fatma Ocal, Didem Fatma Yucel Yetiskin, Derya Uyan Hendem, Gul Nihal Buyuk, Sule Goncu Ayhan, Atakan Tanacan, A Seval Ozgu-Erdinc, Ozlem Moraloglu Tekin, Dilek Sahin

Open access · greenAbstract read
In one paragraph

Article in The Journal of steroid biochemistry and molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. COVID-19: Consequences on pregnant women and neonates.Health sciences review (Oxford, England) · 2022
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Selcan SinaciDepartment of Obstetrics and Gynecology, Ministry of Health, Ankara City Hospital, Ankara, Turkey. Electronic address: selcansinaci@gmail.com.
Doga Fatma OcalDepartment of Obstetrics and Gynecology, Ministry of Health, Ankara City Hospital, Ankara, Turkey.
Didem Fatma Yucel YetiskinDepartment of Obstetrics and Gynecology, Ministry of Health, Ankara City Hospital, Ankara, Turkey.
Derya Uyan HendemDepartment of Obstetrics and Gynecology, Ministry of Health, Ankara City Hospital, Ankara, Turkey.
Gul Nihal BuyukDepartment of Obstetrics and Gynecology, Ministry of Health, Ankara City Hospital, Ankara, Turkey.
Sule Goncu AyhanDepartment of Obstetrics and Gynecology, Ministry of Health, Ankara City Hospital, Ankara, Turkey.
Atakan TanacanDepartment of Obstetrics and Gynecology, Ministry of Health, Ankara City Hospital, Ankara, Turkey.
A Seval Ozgu-ErdincDepartment of Obstetrics and Gynecology, Ministry of Health, Ankara City Hospital, Ankara, Turkey.
Ozlem Moraloglu TekinDepartment of Obstetrics and Gynecology, Ministry of Health, Ankara City Hospital, Ankara, Turkey; University of Health Sciences, Ankara City Hospital, Ankara, Turkey.
Dilek SahinDepartment of Obstetrics and Gynecology, Ministry of Health, Ankara City Hospital, Ankara, Turkey; University of Health Sciences, Ankara City Hospital, Ankara, Turkey.
Ministry of Health · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe aimed to evaluate the vitamin D status of pregnant women with COVID-19, and the association between vitamin D level and severity of COVID-19.

methodsIn this case control study, 159 women with a single pregnancy and tested positive for SARS-CoV-2, and randomly selected 332 healthy pregnant women with similar gestational ages were included. COVID-19 patients were classified as mild, moderate, and severe. Vitamin D deficiency was defined as 25-hydroxycholecalciferol <20 ng/mL (50 nmol/L), and 25-OH D vitamin <10 ng/mL was defined as severe vitamin D deficiency, also 25-OH D vitamin level between 20-29 ng/mL (525-725 nmol/L) was defined as vitamin D insufficiency.

resultsVitamin D levels of the pregnant women in the COVID-19 group (12.46) were lower than the control group (18.76). 25-OH D vitamin levels of those in the mild COVID-19 category (13.69) were significantly higher than those in the moderate/severe category (9.06). In terms of taking vitamin D supplementation, there was no statistically significant difference between the groups. However, it was observed that all of those who had severe COVID-19 were the patients who did not take vitamin D supplementation.

conclusionThe vitamin D levels are low in pregnant women with COVID-19. Also, there is a significant difference regarding to vitamin D level and COVID-19 severity in pregnant women. Maintenance of adequate vitamin D level can be useful as an approach for the prevention of an aggressive course of the inflammation induced by this novel coronavirus in pregnant women.

Indexed as

Dietary SupplementsAdultCalcifediolCase-Control StudiesCOVID-19Cytokine Release SyndromeFemaleGestational AgeHumansPregnancyPregnancy Complications, InfectiousSARS-CoV-2Severity of Illness IndexTreatment OutcomeVitamin DVitamin D Deficiency25-hydroxyvitamin DCalcifediolVitamin DCOVID-19Cytokine stormImmune systemPregnancyVitamin D deficiency

Identifiers

PMID34390830
PMCPMC8356729
OpenAlexW3188491079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.